Balanced risk set matching

Journal of the American Statistical Association

Volumn 96, Issue 455, 2001, Pages 870-882

  Li, Yunfei Paul ^a   Propert, Kathleen J ^b   Rosenbaum, Paul R ^c  

^a KPMG LLP   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Integer programming; Matched sampling; Network flow; Observational study; Sensitivity analysis

Indexed keywords

EID: 0442327799     PISSN: 01621459     EISSN: 1537274X     Source Type: Journal    
DOI: 10.1198/016214501753208573     Document Type: Article

References (52)

1. Andrews, D. F., Bickel, P. J., Hampel, F. R., Huber, P. J., Rogers, W. H., and Tukey, J. W. (1972), Robust Estimates of Location, Princeton, NJ: Princeton University Press.
2. Angrist, J., Imbens, G., and Rubin, D. (1996), “Identification of Causal Effects Using Instrumental Variables,” Journal of the American Statistical Association, 91, 444–469.
3. Bergstralh, E. J., Kosanke, J. L., and Jacobsen, S. L. (1996), “Software for Optimal Matching in Observational Studies,” Epidemiology, 7, 331–332. Available at http://www.mayo.edu/hsr/sasmac/match.sas.
4. Bertsekas, D. P. (1991), Linear Network Optimization, Cambridge, MA: MIT Press.
5. Cox, D. R. (1958), Planning of Experiments, New York: Wiley.
6. Cox, D. R. (1972), “Regression Models and Life Tables” (with discussion), Journal of the Royal Statistical Society, Ser. B, 74, 187–200.
7. Cox, D. R. (1975), “Partial Likelihood,” Biometrika, 62, 269–276.
8. Curhan, G. C., Speizer, F. E., Hunter, D. J., Curhan, S. G., and Stampfer, M. J. (1999), “Epidemiology of Interstitial Cystitis: A Population Based Study,” Journal of Urology, 161, 549.
9. Fisher, R. A. (1935), Design of Experiments. Edinburgh: Oliver and Bogel.
10. Gu, X. S., and Rosenbaum, P. R. (1993), “Comparison of Multivariate Matching Methods: Structures, Distances and Algorithms,” Journal of Computational and Graphical Statistics, 2, 405–420.
11. Hammond, E. C. (1964), “Smoking in Relation to Mortality and Morbidity,” Journal of the National Cancer Institute, 32, 1161–1188.
12. Hanno, P. M., Landis, J. R., Matthews-Cook, Y., Kusek, J., Nyberg, L., and Interstitial Cystitis Database Study Group (1999), “The Diagnosis of Interstitial Cystitis Revisited,” Journal of Urology, 161, 553.
13. Herbst, A., Ulfelder, H., and Poskanzer, D. (1971), “Adenocarcinoma of the Vagina: Association of Maternal Stibestrol Therapy with Tumor Appearance in Young Women,” New England Journal of Medicine, 284, 878–881.
14. Hollander, M., and Wolfe, D. A. (1999), Nonparametric Statistical Methods, New York: Wiley.
15. Hsu, J. C., Hwang, J. T. G., Liu, H. K., and Ruberg, S. J. (1994), “Con.-dence Intervals Associated With Tests for Bioequivalence,” Biometrika, 81, 103–114.
16. Hunner, G. L. (1918), “A Rare Type of Bladder Ulcer,” Journal of the American Medical Association, 70, 203.
17. Jick, H., Miettinen, O., Neff, R., Shapiro, S., Heinonen, O. P., and Sloan, D. (1973), “Coffee and Myocardial Infarction,” New England Journal of Medicine, 289, 63–77.
18. Joffe, M. M., Hoover, D. R., Jacobson, L. P., Kingsley, L., Chmiel, J. S., Visscher, B. R., and Robins, J. M. (1998), “Estimating the Effect of Zidovudine on Kaposi’s Sarcoma from Observational Data Using a Rank Preserving Structural Failure-Time Model,” Statistics in Medicine, 17, 1073–1102.
19. Keiding, N., Filiberti, M., Esbjerg, S., Robins, J. M., and Jacobsen, N. (1999), “The Graft Versus Leukemia Effect After Bone Marrow Transplantation: A Case-Study Using Structural Nested Failure Time Models,” Biometrics, 55, 23–28.
20. Langholz, B. and Goldstein, L. (1996), “Risk Set Sampling in Epidemiologic Cohort Studies” (with discussion), Statistical Science, 11, 35–53.
21. Lehmann, E. L. (1998), Nonparametrics, Upper Saddle River, NJ: Prentice-Hall.
22. Ming, K., and Rosenbaum, P. R. (2000), “Substantial Gains in Bias Reduction From Matching With a Variable Number of Controls,” Biometrics, 56, 118–124.
23. Neyman, J. (1923), “On the Application of Probability Theory to Agricultural Experiments. Essay on Principles. Reprinted in English in Statistical Science, 1990, 5, 463–480 (with discussion by T. Speed and D. Rubin).
24. Oakes, D. (1981), “Survival Times: Aspects of Partial Likelihood” (with discussion), International Statistical Review, 49, 235–264.
25. Papadimitriou, C. H., and Steiglitz, K. (1982), Combinatorial Optimization: Algorithms and Complexity, Englewood Cliffs, NJ: Prentice-Hall.
26. Pocock, S. J., and Simon, R. (1975), “Sequential Treatment Assignment With Balancing for Prognostic Factors in the Controlled Clinical Trial,” Biometrics, 31, 103–116.
27. Prentice, R. L. (1986), “A Case-Cohort Design for Epidemiologic Cohort Studies and Disease Prevention Trials,” Biometrika, 73, 1–11.
28. Prentice, R. L., and Breslow, N. E. (1978), “Retrospective Studies and Failure Time Models,” Biometrika, 65, 153–158.
29. Propert, K. J., Schaeffer, A., Brensinger, C., Kusek, J. W., Nyberg, L. M., Landis, J. R., and ICDB Study Group (2000), “A Prospective Study of Interstitial Cystitis: Results of Longitudinal Follow-up of the Interstitial Cystitis Database Cohort,” Journal of Urology, 163, 1434–1439.
30. Robins, J. M. (1999), “Association, Causation, and Marginal Structural Models,” Synthese, 121, 151–179.
31. Robins, J. M., Blevins, D., Ritter, G., and Wulfsohn, M. (1992), “G-Estimation of the Effect of Prophylaxis Therapy for Pneumocystis Carinii Pneumonia on the Survival of AIDS Patients,” Epidemiology, 3, 319–336.
32. Rosenbaum, P. R. (1984), “Conditional Permutation Tests and the Propensity Score in Observational Studies,” Journal of the American Statistical Association, 79, 565–574.
33. Rosenbaum, P. R. (1987), “Sensitivity Analysis for Certain Permutation Inferences in Matched Observational Studies,” Biometrika, 74, 13–26.
34. Rosenbaum, P. R. (1988), “Sensitivity Analysis for Matching With Multiple Controls,” Biometrika, 75, 577–581.
35. Rosenbaum, P. R. (1989), “Optimal Matching in Observational Studies,” Journal of the American Statistical Association, 84, 1024–1032.
36. Rosenbaum, P. R. (1991), “A Characterization of Optimal Designs for Observational Studies,” Journal of the Royal Statistical Society, Ser. B, 53, 597–610.
37. Rosenbaum, P. R. (1995), Observational Studies, New York: Springer.
38. Rosenbaum, P. R. (1996), Comment on “Indentification of Causal Effects Using Instrumental Variables by J. Angrist, G. Imbens and D. Rubin,” Journal of the American Statistical Association, 91, 465–468.
39. Rosenbaum, P. R. (1997), “Signed Rank Statistics for Coherent Predictions,” Biometrics, 53, 556–566.
40. Rosenbaum, P. R. (1999a), “Reduced Sensitivity to Hidden Bias at Upper Quantiles in Observational Studies With Dilated Treatment Effects,” Biometrics, 55, 560–564.
41. Rosenbaum, P. R. (1999b), “Using Combined Quantile Averages in Matched Observational Studies,” Applied Statistics, 48, 63–78.
42. Rosenbaum, P. R. (2001), “Effects Attributable to Treatment: Inference in Experiments and Observational StudiesWith a Discrete Pivot,” Biometrika, 88, 219–231.
43. Rosenbaum, P. R. and Rubin, D. B. (1983), “The Central Role of the Propensity Score in Observational Studies of Causal Effects.” Biometrika, 70, 41–55.
44. Rosenbaum, P., and Rubin, D. (1985), “Constructing a Control Group Using Multivariate Matched Sampling Methods That Incorporate the Propensity Score,” American Statistician, 39, 33–38.
45. Rovner, E., Propert, K. J., Brensinger, C., Wein, A. J., Foy, M., Kirkemo, A., Landis, J. R., Kusek, J. W., Nyberg, L. M., and ICDB Study Group (in press), “Treatments Used in Women With Interstitial Cystitis: The Interstitial Cystitis Data Base (ICDB) Study Experience,” Urology.
46. Rubin, D. B. (1974), “Estimating Causal Effects of Treatments in Randomized and Nonrandomized Studies,” Journal of Educational Psychology, 66, 688–701.
47. Rubin, D. B. (1977), “Randomization on the Basis of a Covariate,” Journal of Educational Statistics, 2, 1–26.
48. Rubin, D. B. (1980), “Bias Reduction Using Mahalanobis Metric Matching,” Biometrics, 36, 293–298.
49. Sheiner, L. B., and Rubin, D. B. (1995), “Intention-to-Treat Analysis and the Goals of Clinical Trials,” Clinical Pharmacology and Therapeutics, 57, 6–15.
50. Simon, L. J., Landis, J. R., Erickson, D. R., Nyberg, L. M., and ICDB Study Group (1997), “The Interstitial Cystitis Data Base Study: Concepts and Preliminary Baseline Descriptive Statistics,” Urology, 49, 64–75.
51. Susser, M. (1973), Causal Thinking in the Health Sciences: Concepts and Strategies in Epidemiology, New York: Oxford.
52. Wei, L. J., and Lachin, J. M. (1984), “Two Sample Asymptotically Distribution Free Test for Incomplete Multivariate Observations,” Journal of the American Statistical Association, 79, 653–661.